Winston Pharmaceuticals Inc. (WPHM)
OTC PINK OTC PINK Primary Summary
Winston Pharmaceuticals Inc. (WPHM) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Winston Pharmaceuticals Inc. ever had a stock split?
Winston Pharmaceuticals Inc. Profile
| Pharmaceuticals Industry | Healthcare Sector | Joel E. Bernstein CEO | OTC PINK Exchange | 975657107 CUSIP |
| US Country | 9 Employees | - Last Dividend | 16 Jan 2009 Last Split | - IPO Date |
Overview
Winston Pharmaceuticals, Inc. is a pioneering force in the pharmaceutical industry, dedicated to the discovery, development, and commercialization of innovative therapeutics for the management of pain. The company has carved a niche for itself by focusing on a wide array of pain indications, including episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and the pain and inflammation associated with inflammatory bowel disease. Initially founded as Winston Laboratories, Inc., it underwent a strategic rebranding to Winston Pharmaceuticals, Inc. in November 2008. Established in 1998, the company boasts a strong foundation and operates from its headquarters in Vernon Hills, Illinois.
Products and Services
- Episodic Cluster Headache Treatments
Winston Pharmaceuticals, Inc. offers targeted therapies for the management of episodic cluster headaches, providing patients with relief from this severe and debilitating condition.
- Chronic Migraine Headache Solutions
The company has developed innovative treatments for chronic migraines, aiming to reduce the frequency and severity of migraine episodes, thereby improving the quality of life for sufferers.
- Neuropathic Pain Syndromes Therapeutics
Winston Pharmaceuticals is at the forefront of developing therapies for various neuropathic pain syndromes, focusing on addressing the root causes of nerve pain and offering much-needed relief to patients.
- Osteo- and Rheumatoid Arthritis Treatments
The company's portfolio includes specialized treatments for both osteoarthritis and rheumatoid arthritis, aimed at reducing pain, inflammation, and improving joint function.
- Inflammatory Bowel Disease Pain and Inflammation Management
Winston Pharmaceuticals has also developed treatments to alleviate the pain and inflammation associated with inflammatory bowel disease, providing a therapeutic solution to improve the lives of patients suffering from this condition.
- Niche Indications
Beyond its core focus areas, the company is engaged in the development of treatments for niche indications, underscoring its commitment to addressing unmet medical needs across a spectrum of diseases.
